drugset / Trial / NCT02301884

Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis

NCT02301884

NaSingle-groupOpen-labelTreatment

Summary

The investigators performed open-labeled pilot study which evaluates the efficacy and safety of allergen-specific intralymphatic immunotherapy (ILIT) for allergens including Dermatophagoides farinae (Df), Dermatophagoides pteronyssinus (Dp), cat, and dog that are sensitized and provoke rhinitis-related symptoms in patients with allergic rhinitis.

Timeline

Start
2013-11
Primary completion
2014-12
Completion
2015-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Allergen extract Unknown 0.1 ml Other

Indications